Advertisement

Topics

NeuroTherapeutics Pharma, Inc. Company Profile

00:51 EST 17th December 2018 | BioPortfolio

NeuroTherapeutics Pharma is a privately held life sciences company which is focused on the discovery and development of novel therapeutics for patients suffering from CNS disorders. The company is developing compounds that decrease or eliminate aberrant excitatory discharges by working through a new mechanism of action which is unlike that of any marketed product. NTP’s proprietary molecules target a novel molecular site that will create a pipeline of potential new treatments for multiple CNS disorders. NTP-2014, the company’s lead compound, has exhibited excellent efficacy results in multiple preclinical models of epilepsy, acute and neuropathic pain. NTP-2014 has also demonstrated a very favorable safety profile in IND-enabling (GLP) subchronic toxicology studies. NeuroTherapeutics Pharma is led by a strong management team with significant drug development experience in the CNS space. Additional information can be found at the company's website: www.ntprx.com.


News Articles [471 Associated News Articles listed on BioPortfolio]

Supernus Pharma to Buy Biscayne Neurotherapeutics in Potential $183 Million Deal

Supernus Pharmaceutical, headquartered in Rockville, Maryland, is acquiring Biscayne Neurotherapeutics, located in Miami, Florida.

Supernus Pharma to Buy Biscayne Neurotherapeutics in Potential $183 Million Deal http://dlvr.it/QkBxsD pic.twitter.com/wbIReBAQrT

Supernus Pharma to Buy Biscayne Neurotherapeutics in Potential $183 Million Deal http://dlvr.it/QkBxsD  pic.twitter.com/wbIReBAQrT

$SUPN to Acquire Biscayne Neurotherapeutics. M&A here we go.. https://globenewswire.com/news-release/2018/09/13/1570828/0/en/Supernus-to-Acquire-Biscayne-Neurotherapeutics.html …

$SUPN to Acquire Biscayne Neurotherapeutics. M&A here we go.. https://globenewswire.com/news-release/2018/09/13/1570828/0/en/Supernus-to-Acquire-Biscayne-Neurotherapeutics.html …

Supernus acquires epilepsy start-up Biscayne Neurotherapeutics for up to $183mm

Supernus Pharmaceuticals Inc. agreed to acquire epilepsy-focused start-up Biscayne Neurotherapeutics Inc. (BNT) for up to $183mm.

Supernus Gains Epilepsy Drug through Acquisition of Biscayne Neurotherapeutics

ROCKVILLE, Md., Sept. 13, 2018 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment ...

Supernus to Acquire Biscayne Neurotherapeutics

Adds Phase 1 Novel Epilepsy Development Program ROCKVILLE, Md., Sept. 13, 2018 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a pharmaceutical company focused on developing and...

Positive-allosteric modulation of the 5-HT2C receptor: implications for neuropsychopharmacology and neurotherapeutics

Supernus Pharmaceuticals ($SUPN) to Acquire Biscayne Neurotherapeutics, Adding #Epilepsy Candidate: http://ow.ly/Q6DP30lP4zt pic.twitter.com/PpMc08waKC

Supernus Pharmaceuticals ($SUPN) to Acquire Biscayne Neurotherapeutics, Adding #Epilepsy Candidate: http://ow.ly/Q6DP30lP4zt  pic.twitter.com/PpMc08waKC

Drugs and Medications [238 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

Clinical Trials [86 Associated Clinical Trials listed on BioPortfolio]

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)

The present clinical trial will be conducted in order to compare the bioavailability of rivastigmine and to assess bioequivalence at steady-state of the Test product RID-TDS 9.5 mg/24 h (L...

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed Condition

The primary objective is to determine clinical bioequivalence of Amphotericin B liposome for injection of Auromedics Pharma LLC, USA and AmBisome (Amphotericin B) liposome for injection of...

Companies [787 Associated Companies listed on BioPortfolio]

NeuroTherapeutics Pharma, Inc.

NeuroTherapeutics Pharma is a privately held life sciences company which is focused on the discovery and development of novel therapeutics for patients suffering from CNS disorder...

Embera NeuroTherapeutics Inc.

Embera NeuroTherapeutics, Inc. is a development-stage pharmaceutical company focused on treating a broad range of addictions where the major clinical challenge is a limited range ...

Embera NeuroTherapeutics, Inc.

Embera NeuroTherapeutics, Inc. is a development stage pharmaceutical company focused on treating a broad range of addictions and obesity where the major clinical challenge is a li...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

More Information about "NeuroTherapeutics Pharma, Inc." on BioPortfolio

We have published hundreds of NeuroTherapeutics Pharma, Inc. news stories on BioPortfolio along with dozens of NeuroTherapeutics Pharma, Inc. Clinical Trials and PubMed Articles about NeuroTherapeutics Pharma, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NeuroTherapeutics Pharma, Inc. Companies in our database. You can also find out about relevant NeuroTherapeutics Pharma, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Epilepsy
Epilepsy is defined as a disorder of brain function characterized by recurrent seizures that have a sudden onset.  (Oxford Medical Dictionary).  A seizure is caused by a sudden burst of excess electrical activity in the brain, causing a tempora...


Corporate Database Quicklinks



Searches Linking to this Company Record